Modern pharmacologic approaches allow the relative contribution of each receptor to be quantitatively tuned, mitigating adverse effects while preserving efficacy ( 5.3 Central neuropeptides and the behavioral dimension of feeding Beyond gut-derived peptides, centrally expressed neuropeptides exert a profound influence over feeding behavior while simultaneously modulating stress, arousal, and reward pathways
By Phil Cain A survey this week highlighted a 29% reduction in how often users of GLP-1 diet drugs consume alcohol and that they spent nearly a third less on alcohol in hospitality settings and a fifth less at home
A comprehensive proteomic study of platelets in patients with T2DM and mild cognitive impairment (T2DM-MCI) versus those without (T2DM-nMCI) revealed that differentially expressed proteins are primarily involved in amyloidosis, mitochondrial autophagy, and insulin signaling pathways (Yu et al., 2021)
Semaglutides FLOW trial subsequently showed a 24% reduction in kidney-disease progression, prompting payers to waive prior authorizations for diabetic nephropathy cases
have produced a proteomic analysis of synaptosomal Shank3 complexes isolated from the enhanced green fluorescent protein Shank3 transgenic mice [340]